Document And Entity Information (USD $)	12 Months Ended
Document And Entity Information (USD $)	Dec. 31, 2014	Feb. 27, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	LIQUIDMETAL TECHNOLOGIES INC
Document Type	10-K
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		464,482,819
Entity Public Float			$ 103,017,155
Amendment Flag	false
Entity Central Index Key	0001141240
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash	$ 10,009,000	$ 2,062,000
Trade accounts receivable, net of allowance for doubtful accounts	83,000	215,000
Prepaid expenses and other current assets	374,000	412,000
Total current assets	10,466,000	2,689,000
Property and equipment, net	1,118,000	249,000
Patents and trademarks, net	669,000	764,000
Other assets	31,000	401,000
Total assets	12,284,000	4,103,000
Current liabilities:
Accounts payable	155,000	361,000
Accrued liabilities	705,000	710,000
Convertible note, net of debt discount	0	0
Embedded conversion feature liability	0	0
Total current liabilities	860,000	1,071,000
Long-term liabilities
Warrant liabilities	2,005,000	4,921,000
Other long-term liabilities	856,000	856,000
Total liabilities	3,721,000	6,848,000
Shareholders' equity (deficit):
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively	0	0
Common stock, $0.001 par value; 700,000,000 shares authorized; 464,482,819 and 375,707,190 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively	464,000	376,000
Warrants	18,179,000	18,179,000
Additional paid-in capital	200,610,000	182,832,000
Accumulated equity (deficit)	(210,636,000)	(204,090,000)
Non-controlling interest in subsidiary	(54,000)	(42,000)
Total shareholders' equity (deficit)	8,563,000	(2,745,000)
Total liabilities and shareholders' equity (deficit)	$ 12,284,000	$ 4,103,000

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	700,000,000	700,000,000
Common stock, shares issued	464,482,819	375,707,190
Common stock, shares outstanding	464,482,819	375,707,190

Consolidated Statements of Operations and Comprehensive Loss (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenue
Products	$ 565	$ 1,007
Licensing and royalties	38	19
Total revenue	603	1,026
Cost of revenue	483	774
Gross margin	120	252
Operating expenses
Selling, marketing, general and administrative	7,463	5,157
Research and development	1,596	1,156
Total operating expenses	9,059	6,313
Operating loss	(8,939)	(6,061)
Change in value of warrants, gain (loss)	2,700	(2,155)
Change in value of embedded conversion feature liability, gain		621
Debt discount amortization expense	(373)	(6,504)
Other income	30
Interest expense		(245)
Interest income	24	5
Gain on extinguishment of debt (Note 11)		91
Loss before income taxes	(6,558)	(14,248)
Net loss and comprehensive loss	(6,558)	(14,248)
Net loss attributable to non-controlling interest	12	42
Net loss and comprehensive loss attributable to Liquidmetal Technologies shareholders	$ (6,546)	$ (14,206)
Net loss per common share attributable to Liquidmetal Technologies shareholders, basic (in Dollars per share)	$ (0.01)	$ (0.04)
Net loss per common share attributable to Liquidmetal Technologies shareholders, diluted (in Dollars per share)	$ (0.01)	$ (0.04)
Number of weighted average shares - basic (in Shares)	441,439,018	341,451,559
Number of weighted average shares - diluted (in Shares)	441,439,018	341,451,559

Consolidated Statement of Shareholders' Equity (Deficit) (USD $) In Thousands, except Share data	Preferred Stock [Member]	Common Stock [Member] USD ($)	Warrant [Member] USD ($)	Additional Paid-in Capital [Member] USD ($)	Retained Earnings [Member] USD ($)	Noncontrolling Interest [Member] USD ($)	Total USD ($)
Balance at Dec. 31, 2012
Conversion of preferred stock		$ 17		$ (17)			$ 222
Conversion of preferred stock (in Shares)	(506,936)	16,896,070
Common stock issuance		116		12,137			12,253
Common stock issuance (in Shares)		116,136,796
Stock option exercises		1		74			75
Stock option exercises (in Shares)		600,000					(600,000)
Stock-based compensation				213			213
Restricted stock issued to officer				312			312
Dividend distribution				222			222
Net loss					(14,206)	(42)	(14,248)
Balance at Dec. 31, 2013		376	18,179	182,832	(204,090)	(42)	(2,745)
Balance (in Shares) at Dec. 31, 2013		375,707,190
Common stock issuance		85		15,915			16,000
Common stock issuance (in Shares)		85,355,615
Warrant exercises		1		225			226
Warrant exercises (in Shares)		1,178,000
Stock option exercises		2		203			205
Stock option exercises (in Shares)		2,242,014					(2,242,014)
Stock-based compensation				907			907
Restricted stock issued to officer				312			312
Reclassification of warrant liability to equity upon exercise				216			216
Net loss					(6,546)	(12)	(6,558)
Balance at Dec. 31, 2014		$ 464	$ 18,179	$ 200,610	$ (210,636)	$ (54)	$ 8,563
Balance (in Shares) at Dec. 31, 2014		464,482,819

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Operating activities:
Net loss	$ (6,558)	$ (14,248)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	301	214
Gain on sale of fixed asset	(5)
Bad debt expense		11
Stock-based compensation	907	213
Restricted stock compensation issued to officer	312	312
(Gain) Loss from change in value of warrants	(2,700)	2,155
Gain from change in value of embedded conversion feature liability		(621)
Gain on extinguishment of debt (Note 11)		(91)
Debt discount amortization	373	6,504
Non-cash interest expense		242
Changes in operating assets and liabilities:
Trade accounts receivable	132	(162)
Prepaid expenses and other current assets	38	(83)
Other assets	(3)
Accounts payable and accrued expenses	(216)	577
Net cash used in operating activities	(7,419)	(4,977)
Investing Activities:
Purchases of property and equipment	(1,061)	(185)
Proceeds from sale of fixed assets	5	1
Investment in patents and trademarks	(9)	(13)
Net cash used in investing activities	(1,065)	(197)
Financing Activities:
Proceeds from exercise of stock options	205	74
Proceeds from exercise of warrants	226
Proceeds from stock issuance	16,000
Net cash provided by financing activities	16,431	74
Net increase (decrease) in cash	7,947	(5,100)
Cash at beginning of period	2,062	7,162
Cash at end of period	10,009	2,062
Supplemental Schedule of Non-Cash Investing and Financing Activities:
Pre-installment payment of convertible debt through common stock issuance		7,187
Dividends paid in common stock upon preferred stock conversion		222
Financing costs paid through common stock issuance		373
Accrued capital expenditures	$ 5

Note 1 - Description of Business

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Business Description and Basis of Presentation [Text Block]

1. Description of Business

Liquidmetal Technologies, Inc. (the “Company”) is a materials technology company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilizes the advantages offered by amorphous alloys technology. The Company designs, develops and sells products and components from bulk amorphous alloys to customers in various industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products. The Company believes that its proprietary bulk alloys are the only commercially viable bulk amorphous alloys currently available in the marketplace.

Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. For example, in laboratory testing, zirconium-titanium Liquidmetal alloys are approximately 250% stronger than commonly used titanium alloys such as Ti-6Al-4V, but they also have some of the beneficial processing characteristics more commonly associated with plastics. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.

The Company’s revenues are derived from i) selling bulk Liquidmetal alloy products, which include non-consumer electronic devices, medical products, automotive components, and sports and leisure goods, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development, iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

Note 2 - Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Basis of Presentation and Significant Accounting Policies [Text Block]

2. Summary of Significant Accounting Policies

Principles of Consolidation. The consolidated financial statements include the accounts of Liquidmetal Technologies, Inc., its special-purpose wholly-owned subsidiary, Crucible Intellectual Property, and Liquidmetal Golf. All intercompany balances and transactions have been eliminated.

Non-Controlling Interest. The results of operations attributable to the non-controlling interest of Liquidmetal Golf are presented within equity and are shown separately from the Company’s equity.

Revenue Recognition. Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic 605 (“ASC 605”), Revenue Recognition. ASC 605 summarize certain points of the SEC staff’s views in applying generally accepted accounting principles to revenue recognition in financial statements and provides guidance on revenue recognition issues in the absence of authoritative literature addressing a specific arrangement or a specific industry.

The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of the sales and prototyping of Liquidmetal molds and bulk alloys, licensing and royalties for the use of the Liquidmetal brand and bulk Liquidmetal alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.

License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.

Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

Cash. The Company considers all highly liquid investments with maturity dates of three months or less when purchased to be cash equivalents. The Company limits the amount of credit exposure to each individual financial institution and places its temporary cash into investments of high credit quality with a financial institution that exceeds federally insured limits. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of December 31, 2014 and 2013, the Company held no deposits in such highly liquid investments.

Trade Accounts Receivable. The Company grants credit to its customers generally in the form of short-term trade accounts receivable. The creditworthiness of customers is evaluated prior to signing a contract with the customer. As of December 31, 2014, two customers represented 100%, or $83, of the total outstanding trade accounts receivable. As of December 31, 2013, three customers represented 99%, or $212, of the total outstanding trade accounts receivable. During 2014, there were four major customers, who together accounted for 84% of the revenue. During 2013, there was one major customer, who accounted for 80% of the revenue. In the future, the Company expects that a significant portion of the revenue may continue to be concentrated in a limited number of customers, even if the bulk alloys business grows.

The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable. Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends. The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the accompanying consolidated statements of operations and comprehensive loss. At December 31, 2014 and 2013, the Company had not recorded an allowance for doubtful accounts.

Property and Equipment. Property and equipment are stated at cost less accumulated depreciation and amortization. Additions and major renewals are capitalized. Repairs and maintenance are charged to expense as incurred. Upon disposal, the related cost and accumulated depreciation are removed from the accounts, with the resulting gain or loss included in operating income. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which range from one to five years.

Intangible Assets. Intangible assets consist of the costs incurred to purchase patent rights and costs incurred to register and maintain patents and trademarks. Intangible assets are reported at cost, net of accumulated amortization. Patents and trademarks are amortized using the straight-line method over a period based on their contractual lives ranging from ten to seventeen years.

Impairment of Long-lived Assets. The Company reviews long-lived assets to be held and used in operations for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may be impaired. These evaluations may result from significant decreases in the market price of an asset, a significant adverse change in the extent or manner in which an asset is being used in its physical condition, a significant adverse change in legal factors or in the business climate that could affect the value of an asset, as well as economic or operational analyses. An impairment loss is recognized when the estimated fair value of the assets is less than the carrying value of the assets. Based on the Company’s review of both qualitative and quantitative factors no significant indicators of impairment were identified during the years ended December 31, 2014 and 2013, respectively.

Fair Value Measurements. The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash and trade receivables, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate their carrying value due to their short maturities. The fair value of non-current assets and liabilities approximate their carrying value unless otherwise stated.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

Level 1 —

Quoted prices in active markets for identical assets or liabilities;

Level 2 —

Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3 —

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company has one Level 2 financial instrument, namely warrant liabilities that are recorded at fair value on a periodic basis. Warrants are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such warrants is estimated using the Black-Scholes option-pricing model. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815 (see note 12).

The Company had one Level 3 financial instrument during the year ended December 31, 2013, that being an embedded derivative that was recorded at fair value on a periodic basis. The embedded derivative was evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such embedded derivative was estimated using the Monte Carlo simulation model. The foregoing embedded derivative had certain anti-dilution and exercise price reset provisions which qualified the embedded derivative to be classified as a liability under FASB ASC 815. Upon the final settlement of the Senior Convertible Notes, this liability was extinguished as the underlying conversion option had been executed. As such, the fair value of the liability was reduced to zero upon conversion (see note 11).

As of December 31, 2014, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities		-		-		2,005		-

As of December 31, 2013, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities		-		-		4,921		-

Research and Development Expenses. Research and development expenses represent salaries, related benefits expense, expenses incurred for the design and testing of new processing methods and other expenses related to the research and development of Liquidmetal alloys. Development costs incurred in research and development activities are expensed as incurred.

Advertising and Promotion Expenses. Advertising and promotion expenses are expensed when incurred. Advertising and promotion expenses were $252 and $78, for the years ended December 31, 2014 and 2013, respectively.

Legal Costs. Legal costs are expensed as incurred.

Stock-Based Compensation. The Company accounts for share-based compensation in accordance with the fair value recognition provisions of FASB ASC Topic 718, Share-based Payment, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the consolidated financial statements based on their fair values. The fair value of stock options is calculated by using the Black-Scholes option pricing formula that requires estimates for expected volatility, expected dividends, the risk-free interest rate and the term of the option. If any of the assumptions used in the Black-Scholes model change significantly, share-based compensation expense may differ materially in the future from that recorded in the current period.

Income Taxes. Income taxes are provided under the asset and liability method as required by FASB ASC Topic 740, Accounting for Income Taxes. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. The effect of a tax rate change on deferred taxes is recognized in operations in the period that the change in the rate is enacted. Valuation allowances are established when necessary to reduce net deferred tax assets to the amount expected to be realized. Under the provisions of FASB ASC Topic 740, the Company had no material unrecognized tax positions and no adjustments to liabilities or operations were required. The Company, when applicable, will recognize interest and penalties related to uncertain tax positions in income tax expense. There was no expense related to interest and penalties for the years ended December 31, 2014 and 2013.

Earnings Per Share. Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. These management estimates are primarily related to impairment of long-lived assets, allowance for bad debt account balances, and warrant valuation.

Subsequent Events. The Company evaluated subsequent events through the filing of its Annual Report on Form 10-K with the SEC.

Recent Accounting Pronouncements.

Presentation of Unrecognized Tax Benefits

In July 2013, the FASB issued an accounting standards update which will require that an unrecognized tax benefit be presented on the balance sheet as a reduction of a deferred tax asset for a net operating loss or tax credit carryforward under certain circumstances. The adoption of this pronouncement did not have a material impact on the Company’s Consolidated Financial Statements and accompanying disclosures.

Revenue from Contracts with Customers

In May 2014, the FASB issued an accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective beginning January 1, 2017 and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements.

Ability to Continue as a Going Concern

In August 2014, the FASB issued an accounting standards update which requires an assessment of an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently addressed by U.S. auditing standards. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company is currently evaluating the new guidance to determine the impact it will have on its consolidated financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Note 3 - Significant Transactions

12 Months Ended

Dec. 31, 2014

Significant Transactions [Abstract]

Significant Transactions [Text Block]

3. Significant Transactions

2014Stock Purchase Agreement

On August 20, 2014, the Company entered into a common stock purchase agreement (“2014 Purchase Agreement”) with Aspire Capital Fund LLC (“Aspire Capital”), which provides that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of $30,000 worth of the Company’s common stock, $0.001 par value, over the 36-month term of the 2014 Purchase Agreement.

From time to time over the term of the 2014 Purchase Agreement, the Company may, at its sole discretion, provide Aspire Capital with a regular purchase notice (each a “Regular Purchase Notice”) directing Aspire Capital to purchase up to 1,000,000 shares, but not to exceed $400, of the Company’s common stock per trading day at a price per share equal to the lesser of (i) the lowest sale price of the Company’s common stock on the purchase date; or (ii) the arithmetic average of the three lowest closing sale prices for the Company’s common stock during the twelve consecutive trading days ending on the trading day immediately preceding the purchase date.

In addition, on any date on which the Company submits a Regular Purchase Notice to Aspire Capital for the purchase of at least 500,000 shares at a price above $0.30, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of the Company’s common stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is generally 95% of the volume-weighted average price for the Company’s common stock traded on its principal market on the VWAP Purchase Date.

The Company may deliver multiple Regular Purchase Notices and VWAP Purchase Notices to Aspire Capital from time to time during the term of the 2014 Purchase Agreement, so long as the most recent purchase has been completed. The 2014 Purchase Agreement provides that the Company and Aspire Capital shall not effect any sales under the 2014 Purchase Agreement on any purchase date where the closing sale price of the Company’s common stock is less than $0.10 per share. There are no trading volume requirements or restrictions under the 2014 Purchase Agreement, and the Company will control the timing and amount of sales of the Company’s common stock to Aspire Capital.

On September 9, 2014, an initial registration statement covering 75,000,000 shares issued and issuable pursuant to the 2014 Purchase Agreement was declared effective by the SEC. To date, there have been no transactions under this agreement.

2013 Stock Purchase Agreement

On November 8, 2013, the Company entered into a Common Stock Purchase Agreement (the “2013 Purchase Agreement”) with Kingsbrook Opportunities Master Fund LP, Tech Opportunities LLC, and Iroquois Master Fund Ltd. (each, a “2013 Investor” and collectively, the “2013 Investors”). The 2013 Purchase Agreement provided that, upon the terms and subject to the conditions set forth therein, each of the 2013 Investors had committed to purchase such 2013 Investor’s pro rata portion of up to $20,000 (the “Total Commitment”) worth of the Company’s common stock, $0.001 par value (the “Shares”), over the 36-month term of the 2013 Purchase Agreement. In consideration for the execution and delivery of the 2013 Purchase Agreement, on November 8, 2013, the Company issued 2,666,667 shares of common stock (“the Commitment Shares”) to the 2013 Investors.

From time to time over the term of the 2013 Purchase Agreement, the Company was able to, at its sole discretion, provide each of the 2013 Investors with draw down notices (each a “Draw Down Notice”) requiring them to purchase a specified dollar amount of Shares (the “Draw Down Amount”) over a five (5) consecutive trading day period commencing on the trading day specified in the applicable Draw Down Notice (the “Pricing Period”) with each draw down subject to the limitations discussed below. The maximum amount of Shares requested to be purchased pursuant to any single Draw Down Notice could not exceed a dollar amount equal to the lesser of (i) 300% of the average trading volume of the Company’s common stock during the ten (10) trading days immediately preceding the date the applicable Draw Down Notice was delivered (the “Applicable Draw Down Exercise Date”) multiplied by the lower of (A) the closing trade price of the Company’s common stock on the trading day immediately preceding the Applicable Draw Down Exercise Date and (B) the average of the closing trade prices of our common stock for the three (3) trading days immediately preceding the Applicable Draw Down Exercise Date (such lower price, the “Reference Price”), and (ii) a specified dollar amount set forth in the 2013 Purchase Agreement based on the Reference Price as of the Applicable Draw Down Exercise Date.

Once presented with a Draw Down Notice, each of the 2013 Investors was required to purchase such 2013 Investor’s pro rata portion of the applicable Draw Down Amount on each trading day during the applicable Pricing Period on which the daily volume weighted average price for the Company’s common stock (the “VWAP”) equaled or exceeded an applicable floor price equal to the product of (i) 0.775 and (ii) the Reference Price, subject to adjustment (the “Floor Price”), provided that in no event could the Floor Price be less than $0.03875. If the VWAP fell below the applicable Floor Price on any trading day during the applicable Pricing Period, the 2013 Purchase Agreement provided that the 2013 Investors would not be required to purchase their pro rata portions of the applicable Draw Down Amount allocated to that trading day. The per share purchase price for the Shares subject to a Draw Down Notice was equal to 90% of the lowest daily VWAP that equaled or exceeded the applicable Floor Price during the applicable Pricing Period. Each purchase pursuant to a Draw Down Notice reduced, on a dollar-for-dollar basis, the Total Commitment under the 2013 Purchase Agreement.

The Company was prohibited from issuing a Draw Down Notice if (i) the amount requested in such Draw Down Notice exceeded certain caps based on trading volume and price, (ii) the sale of Shares pursuant to such Draw Down Notice caused the Company to issue or sell or the 2013 Investors to acquire or purchase an aggregate dollar value of Shares that exceeded the Total Commitment, (iii) the sale of Shares pursuant to the Draw Down Notice caused the Company to sell or the 2013 Investors to purchase an aggregate number of shares of the Company’s common stock which resulted in the collective beneficial ownership by the 2013 Investors of more than 9.99% of the Company’s common stock (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder), or (iv) the applicable Floor Price was less than $0.03875 on the Applicable Draw Down Exercise Date. The Company could not make more than one draw down in any Pricing Period and must have allowed two (2) trading days to elapse between the completion of the settlement of any one draw down and the commencement of a Pricing Period for any other draw down.

On February 11, 2014, an initial registration statement covering 96,555,893 shares issued and issuable pursuant to the 2013 Purchase Agreement was declared effective by the SEC.

As of December 31, 2014, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014.

July 2012 Private Placement

On July 2, 2012, the Company entered into a private placement transaction (the “July 2012 Private Placement”) pursuant to which the Company issued $12,000 in principal amount of senior convertible notes that were due on September 1, 2013. The notes were convertible into shares of the Company’s common stock at a conversion price of $0.352 per share. The notes bore interest at 8% per annum and were payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012. Each monthly installment payment was payable in cash, shares of the Company’s common stock, or a combination thereof. If paid in shares, such shares were valued at the lower of (i) the then applicable conversion price or (ii) a price that was 87.5% of the arithmetic average of the ten (or in some cases fewer) lowest weighted average prices of the Company’s common stock during the twenty trading day period ending two trading days before the payment date or the date on which the Company elected to pay in shares, whichever was lower. As of July 17, 2013, the Company had issued 163,641,547 shares of common stock in full satisfaction of the notes (see note 11).

As a part of the July 2012 Private Placement, the Company issued warrants to purchase 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share (reduced to $0.19 per share under the anti-dilution and price reset provisions of the warrants, see note 12), and such warrants first became exercisable on January 2, 2013 which was six months after the issuance date thereof. In the event that the Company issues or sells shares of the Company’s common stock at a price per share that is less than the exercise price then in effect, the exercise price of the warrants will be reduced based on a weighted-average formula. In addition, on the two-year anniversary of the issuance date, the then applicable exercise price was reset to equal 87.5% of the arithmetic average of the ten lowest weighted average prices of the common stock during the twenty trading day period ending two trading days immediately preceding the reset date. All of the warrants will expire on July 2, 2017 (see note 12).

June 2012 Visser MTA

On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing.

Under the manufacturing and service component of the Visser MTA, the Company had agreed to engage Visser as a perpetual, exclusive manufacturer of non-consumer electronic products and to not, directly or indirectly, conduct manufacturing operations, subcontract for the manufacture of products or components or grant a license to any other party to conduct manufacturing operations, except for certain limited exceptions. Under the financing component of the Visser MTA, the Company issued and sold to Visser in a private placement transaction (i) 30,000,000 shares of common stock at a purchase price of $0.10 per share resulting in proceeds of $3,000, (ii) warrants to purchase 15,000,000 shares of common stock at an original exercise price of $0.22 per share which were to expire on June 1, 2017 and (iii) a secured convertible promissory note in the aggregate principal amount of up to $2,000. No borrowings were made by the Company under the promissory note, and the deadline for making borrowings under the facility expired on November 15, 2012.

In November 2013, the Company and Visser entered into arbitration proceedings to resolve disputes associated with the Visser MTA.

On May 20, 2014, the Company and Visser entered into a settlement agreement under which they agreed to terminate the existing arbitration proceedings, release each other from all claims against each other and substantially change the business relationship that had been reflected in the original Visser MTA. As part of the settlement, the parties have amended and restated the sublicense and financing components of the Visser MTA. Additionally, the manufacturing services component and remaining considerations of the Visser MTA were terminated.

Under the amended and restated sublicense agreement, the Company has granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014 (the “Effective Date”), for all fields of use other than certain excluded fields as set forth therein. Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date. The license to the Company’s intellectual property developed on or prior to the Effective Date does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement.

With the foregoing revised arrangements, the Company is no longer required to use Visser as its exclusive manufacturer and is free to license other manufacturers on a non-exclusive basis in any industry or geographic market as to which the Company has not previously granted an exclusive license to a third party. Any such manufacturers licensed by the Company in the future will be able both to manufacture parts for the Company and the Company’s customers, and to manufacture and sell products for their own account for such industries or markets as the Company may agree, subject to whatever royalty arrangements the Company may negotiate. The Company has not yet licensed any manufacturers other than Visser. Visser will also have the right to manufacture and sell products under the amended and restated sublicense agreement.

The settlement amends and restates two warrants the Company issued to Visser in June 2012 to purchase 15,000,000 shares of the Company’s common stock at an exercise price of $0.22 per share. Those warrants contained anti-dilution mechanisms under which the number of shares issuable upon exercise of those warrants would be increased, and the exercise price for such shares would be reduced if the Company issued shares of its common stock at prices less than the warrants’ exercise price. The amended and restated warrant agreement includes the effect of such anti-dilution adjustments and is exercisable for 18,611,079 shares of common stock (increased further to 18,706,235 shares under the anti-dilution provisions of the warrants, see note 12) at an exercise price of $0.18 per share. The amended and restated warrant agreement continues to contain comparable anti-dilution adjustment mechanisms. The amended and restated warrant agreement also removes certain lock-up provisions that were included in the original warrants.

Apple License Transaction

On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Additionally, in connection with the license transaction, Apple required the Company to complete a statement of work related to the exchange of Liquidmetal intellectual property information. The Company recognized a portion of the one-time license fee upon receipt of the initial payment and completion of the foregoing requirements under the license transaction. The remaining portion of the one-time license fee was recognized at the completion of the required statement of work.

Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property that it developed through February 2012. Subsequently, this obligation has been extended to apply to all intellectual property developed through February 2015. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.

Other License Transactions

On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel. On December 6, 2013, the companies entered into an Exclusive License Agreement for a 10 year term whereby Engel was granted an exclusive license to manufacture and sell injection molding machines to the Company’s licensees in exchange for certain royalties to be paid by Engel to the Company based on a percentage of the net sales price of such injection molding machines.

The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. The Company owns 79% of the outstanding common stock of Liquidmetal Golf.

In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”). Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021.

In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches and all third parties (including the Company), but non-exclusive as to Apple, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

Note 4 - Liquidity and Going Concern Issues

12 Months Ended

Dec. 31, 2014

Liquidityand Capital Resource [Abstract]

Liquidityand Capital Resource [Text Block]

4. Liquidity and Going Concern Issues

The Company’s cash used in operations was $7,419 for the year ended December 31, 2014, while cash used in operations was $4,977 for the year ended December 31, 2013. The Company’s cash used in investing activities was $1,065 for the year ended December 31, 2014 primarily consisting of capital expenditures to support the manufacturing efforts of the Company. The Company’s cash provided by financing activities was $16,431 for the year ended December 31, 2014 primarily from proceeds from stock issuances under the 2013 Purchase Agreement and stock option and warrant exercises. As of December 31, 2014, the Company’s cash balance was $10,009.

On August 20, 2014, the Company entered into the 2014 Purchase Agreement which allows it to raise up to $30,000 through periodic issuances of common stock over a three year period. As of December 31, 2014, the Company has not executed any transactions under this agreement.

On November 8, 2013, the Company entered into the 2013 Purchase Agreement which allowed it to raise up to $20,000 through periodic issuances of common stock over a three year period. During the year ended December 31, 2014, the Company received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. This agreement was effectively terminated on August 25, 2014.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary if the Company were unable to continue as a going concern. The Company has a relatively limited history of producing bulk amorphous alloy components and products on a mass-production scale. Furthermore, the ability of future contract manufacturers to produce the Company’s products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of the Company’s control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. These factors will likely require that the Company make future equity sales under the 2014 Purchase Agreement, raise additional funds by other means, or pursue other strategic initiatives to support its operations beyond 2015 and into 2016. There is no assurance that the Company will be able to make equity sales under the 2014 Purchase Agreement or raise additional funds by other means on acceptable terms, if at all. If the Company were to make equity sales under the 2014 Purchase Agreement or to raise additional funds through other means by issuing securities, existing stockholders may be diluted. If funding is insufficient at any time in the future, the Company may be required to alter or reduce the scope of its operations or to cease operations entirely. Uncertainty as to the outcome of these factors raises substantial doubt about the Company’s ability to continue as a going concern.

Note 5 - Trade Accounts Receivable

12 Months Ended

Dec. 31, 2014

Receivables [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

5. Trade accounts receivable

Trade accounts receivable were comprised of the following:

	December 31,
	2014		2013
Trade accounts receivable	$	83	$	215
Less: Allowance for doubtful accounts		-		-
Trade accounts receivable, net	$	83	$	215

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References+ Details

Note 7 - Property and Equipment

12 Months Ended

Dec. 31, 2014

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

7. Property and Equipment

Property and equipment consist of the following:

	December 31,
	2014			2013

Machinery and equipment	$	1,903		$	1,107
Computer equipment		218			203
Office equipment, furnishings, and improvements		531			277
Total		2,652			1,587
Accumulated depreciation		(1,534	)		(1,338	)
Total property and equipment, net	$	1,118		$	249

Depreciation expense for the years ended December 31, 2014 and 2013 were $197 and $96, respectively, and is included in selling, marketing and general and administrative expense in the consolidated statements of operations and comprehensive loss.

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details

Note 8 - Patents and Trademarks, Net

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Intangible Assets Disclosure [Text Block]

8. Patents and trademarks, net

Patents and trademarks consist of the following:

	December 31,
	2014			2013

Purchased and licensed patent rights	$	566		$	566
Internally developed patents		1,664			1,664
Trademarks		148			139
Total		2,378			2,369
Accumulated amortization	$	(1,709	)	$	(1,605	)
Total intangible assets, net	$	669		$	764

Amortization expense was $104 and $118 for the years ended December 31, 2014 and 2013, respectively, and is included in research and development expense in the consolidated statements of operations and comprehensive loss. The estimated aggregate amortization expense for each of the five succeeding years is as follows:

December 31,	Aggregate Amortization Expense
2015		99
2016		97
2017		85
2018		85
2019		82
Thereafter		221
	$	669

Accumulated amortization for the years ended December 31, 2014 and 2013 is as follows:

	December 31,
	2014			2013

Purchased and licensed patent rights	$	(500	)	$	(483	)
Internally developed patents		(1,103	)		(1,022	)
Trademarks		(106	)		(100	)
Total	$	(1,709	)	$	(1,605	)

The weighted average amortization periods for the years ended December 31, 2014 and 2013 are as follows:

	December 31,
	2014		2013

Purchased and licensed patent rights		17		17
Internally developed patents		17		17
Trademarks		10		10

Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees or other amounts will be payable in the future under the license agreements.

In addition to the purchased and licensed patents, the Company has capitalized legal and registration costs incurred to obtain and maintain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

Note 9 - Accrued Liabilities

12 Months Ended

Dec. 31, 2014

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

9. Accrued Liabilities

Accrued liabilities totaled $705 and $710 as of December 31, 2014 and December 31, 2013, respectively. Included within these totals are employee related accruals for normal wages, bonuses, and vacation liabilities, of $567 and $511, as well as accrued audit fees of $95 and $67 as of December 31, 2014 and 2013, respectively. In addition, as of December 31, 2014 and 2013, respectively, $43 and $39 of deferred straight-line rent liabilities existed related to the Company’s warehouse and office facility lease. The 2013 total also includes $93 for remaining payments to be made under financed insurance premiums, which were all paid by the Company during 2014.

Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

11. Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt

On July 2, 2012, the Company entered into the July 2012 Private Placement for $12,000 in principal amount of senior convertible notes due on September 1, 2013 (see note 3). The notes were convertible at any time at the option of the holders, into shares of the Company’s common stock at a conversion price of $0.352 per share. Pursuant to ASC 815-40, due to the anti-dilution provision of the convertible notes, the conversion feature of the convertible notes was not indexed to the Company’s own stock and was bifurcated and recognized as a derivative liability in the consolidated balance sheets and measured at fair value. The notes bore interest at 8% per annum and were payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012.

The embedded conversion feature liability and warrants issued in connection with the senior convertible notes were valued utilizing the Monte Carlo simulation and Black-Scholes pricing model at $8,865 and $5,053, respectively, totaling $13,918 as of July 2, 2012. $12,000 of this total was recorded as debt discount and the excess of the face value of the embedded conversion feature liability and warrants of $1,918 was booked to debt discount amortization on July 2, 2012.

Pursuant to the terms of the Senior Convertible Notes, the Company opted to pay the first eleven monthly installment payments due prior to June 30, 2013 with shares of the Company’s common stock. On July 17, 2013, the Company and each of the holders of the Senior Convertible Notes agreed to cause all remaining principal and interest under the Senior Convertible Notes to be converted into an aggregate of 18,679,584 shares of the Company’s common stock in full satisfaction of the notes. As a result of this conversion, the Senior Convertible Notes were paid off in full and are no longer outstanding as of the conversion date. As the final conversion occurred pursuant to terms that were not included in the original terms of the Senior Convertible Notes, the Company recorded a gain on extinguishment of debt in the amount of $91 which consisted of the write-off of unamortized debt discount, unamortized debt issuance costs, embedded conversion feature liabilities, and the difference between the reacquisition price of the shares issued and the contractual conversion price of the Senior Convertible Notes.

Upon final settlement, the Company had issued 163,641,547 shares of common stock, at a weighted average conversion price of $0.0774, for the twelve installment payments due under the Senior Convertible Notes, consisting of $12,000 principal and $680 of interest.

Interest expense on the Senior Convertible Notes was $0 and $242 for the years ended December 31, 2014 and 2013, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

Note 12 - Warrant Liabilities

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Derivatives and Fair Value [Text Block]

12. Warrant Liabilities

Pursuant to FASB ASC 815, the Company is required to report the value of certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its consolidated statement of operations and comprehensive loss due to the price-based anti-dilution rights of warrants.

During June 2012, the Company issued warrants to purchase a total of 15,000,000 shares of common stock to Visser under the Visser MTA (see note 3). These warrants had an original exercise price of $0.22 per share and expire on June 1, 2017 and were originally valued at $4,260. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of paying down our convertible notes with common stock, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to $0.18 as of December 31, 2013 and December 31, 2014. In addition, the number of shares to be issued under the warrants as a result of the anti-dilution provision increased to 18,562,825 and 18,706,235 as of December 31, 2013 and December 31, 2014, respectively. As of December 31, 2014, these warrants were valued at $1,053 using the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 2.42 years, (ii) volatility of 97%, (iii) risk-free interest rate of 1.10%, and (iv) dividend rate of 0. The change in warrant value for these warrants for the years ended December 31, 2014 and 2013 was a gain (loss) of $1,506 and $(1,299), respectively.

On July 2, 2012, the Company issued warrants to purchase a total of 18,750,000 shares of common stock related to the July 2012 Private Placement (see note 3). These warrants have an exercise price of $0.384 per share and expire on July 2, 2017 and were originally valued at $5,053. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of executed draw-downs under the 2013 Purchase Agreement, which resulted in an anti-dilution impact, as well as contractually defined price resets following the second anniversary of the July 2012 Private Placement, the exercise price of these warrants was reduced to $0.19 as of December 31, 2014. As of December 31, 2014, these warrants were valued at $952 using the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 2.50 years, (ii) volatility of 96%, (iii) risk-free interest rate of 1.10%, and (iv) dividend rate of 0. The change in warrant value for these warrants for the years ended December 31, 2014 and 2013 was a gain (loss) of $1,194 and $(856), respectively.

On July 8, 2014, an investor party to the July 2012 Private Placement exercised 1,178,000 warrants at an exercise price of $0.19 per share. Upon exercise, the Company received $226, and the associated warrant liability of $216 was reclassified to additional paid in capital.

The following table summarizes the change in the Company’s warrant liability for the year ended December 31, 2014:

	Visser MTA			July 2, 2012
	Agreement			Private Placement			Total

Beginning Balance - December 31, 2013	$	2,559		$	2,362			4,921
Change in value of warrant liability, gain	$	(1,506	)	$	(1,194	)		(2,700	)
Reclassification to equity upon warrant exercise		-			(216	)		(216	)
Ending Balance - December 31, 2014	$	1,053		$	952		$	2,005

As of December 31, 2014 and 2013, the Company had 66,057,792 and 67,092,382 warrants outstanding, respectively. As of December 31, 2014 and 2013, the Company valued the 36,278,235 and 37,312,825 warrants classified as liabilities using the Black-Scholes model and recorded $2,005 and $4,921 respectively, in warrant liabilities. The change in fair value of warrants resulted in a total non-cash gain (loss) of $2,700 and $(2,155) for the years ended December 31, 2014 and 2013, respectively.

The fair value of warrants outstanding for the following periods was computed using the Black-Scholes model under the following assumptions:

	December 31,
	2014		2013
Expected life in years		2.42 - 2.50		3.42 - 3.50
Volatility		96% - 97%		142% - 143%
Risk-free interest rate		1.10%		1.75%
Dividend rate		0%		0%

As of December 31, 2014, outstanding warrants to acquire shares of the Company’s common stock are as follows:

Number of Shares		Exercise Price		Expiration Date

	208,334	$	0.480	July 15, 2015
	29,571,223	$	0.490	July 15, 2015
	18,706,235	$	0.176	June 1, 2017
	17,572,000	$	0.192	July 2, 2017
	66,057,792

Note 13 - Shareholders' Equity (Deficit)

12 Months Ended

Dec. 31, 2014

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

13. Shareholders’ Deficit

Common stock

In June 2012, the Company issued 30,000,000 shares of common stock to Visser in connection with the Visser MTA (see note 3).

Pursuant to the terms of the Company’s Senior Convertible Notes issued in the July 2012 Private Placement, the Company opted to pay the twelve monthly installment payments prior to the September 1, 2013 maturity date with shares of the Company’s common stock. Upon final settlement, the Company had issued 163,641,547 shares of common stock at a weighted average conversion price of $0.0774, for the twelve installment payments due under the notes, consisting of $12,000 principal and $680 of interest (see notes 3 and 11).

During the year ended December 31, 2013, the holders of the Company’s Series A Preferred Stock converted all of the outstanding 506,936 shares of preferred stock into 16,896,070 shares of the Company’s common stock (see “Preferred stock” below). After giving effect to such conversion, the Company has no shares of preferred stock outstanding.

On February 28, 2013, the Company’s stockholders approved an amendment to the Certificate of Incorporation of the Company increasing the number of authorized shares of common stock from 400 million shares to 500 million shares.

On October 24, 2013, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 500 million shares to 700 million shares.

In connection with the execution of the November 8, 2013 Common Stock Purchase Agreement, the Company issued to each of the investors a pro rata portion of 2,666,667 shares of the Company’s common stock. During the year ended December 31, 2014, the Company received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share (see note 3).

Preferred stock

On May 1, 2009, pursuant to a Securities Purchase and Exchange Agreement, the Company issued 500,000 shares of convertible Series A-1 Preferred Stock with an original issue price of $5.00 per share and 2,625,000 shares of Series A-2 Preferred Stock with an original issue price of $5.00 per share as part of a financing transaction. In October 2009, the Company entered into an agreement with various investors to issue 180,000 shares of Series A-1 Preferred Stock with identical terms as the Series A-1 Preferred Stock issued on May 1, 2009.

The Series A Preferred Stock and any accrued and unpaid dividends thereon was convertible, at the option of the holders of the Series A Preferred Stock, into common stock of the Company at a conversion price of $0.10 per share in the case of the Series A-1 Preferred Stock and a conversion price of $0.22 per share in the case of the Series A-2 Preferred Stock (in both cases subject to adjustments for any stock dividends, splits, combinations and similar events).

During the year ended December 31, 2012, the holders of the Company’s Series A Preferred Stock converted 792,215 shares of preferred stock into 25,669,752 shares of the Company’s common stock. As of December 31, 2012, the Company had 506,936 shares of Series A Preferred Stock outstanding, consisting of 105,231 and 401,705 shares of Series A-1 and Series A-2 Preferred Stock, respectively. Preferred stock as of December 31, 2012 was $0 due to an insignificant balance, and accrued dividends on the Series A Preferred Stock as of December 31, 2012 were $222.

During the year ended December 31, 2013, all of the holders of the Company’s Series A Preferred Stock converted all of the outstanding shares of preferred stock and accrued dividends into 16,896,070 shares of the Company’s common stock. Therefore, as of December 31, 2013, the Company no longer had any outstanding Preferred Stock and the related $222 accrued dividends were reclassified to additional paid-in capital as of December 31, 2013.

Warrants

In connection with the Series A Preferred Stock issuances, warrants to purchase 29,779,557 shares of the Company’s common stock were outstanding as of December 31, 2013 and December 31, 2014. These warrants do not contain anti-dilution provisions and are reflected as equity as they do not meet the criteria under FASB ASC 815 for liability treatment. Warrants classified as equity were recorded at $18,179 as of December 31, 2013 and December 31, 2014. Such warrants have an exercise price ranging between $0.48 and $0.49 and expire on July 15, 2015.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

Note 14 - Stock Compensation Plan

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

14. Stock Compensation Plan

On April 4, 2002, our shareholders and Board of Directors adopted the 2002 Equity Incentive Plan (“2002 Plan”). The 2002 Plan provides for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of 10,000,000 shares of our common stock may be granted under the 2002 Plan. The 2002 Plan expired by its terms in April 2012, but it will remain in effect only with respect to the equity awards that have been granted prior to its expiration. As of December 31, 2014, there were 1,725,000 options outstanding under the 2002 Plan.

On June 28, 2012, the Company adopted the 2012 Equity Incentive Plan (“2012 Plan”), with the approval of the shareholders, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. The 2012 Plan provides for the granting to employees of incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, and for the granting to employees and consultants of non-statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of thirty million shares of the Company’s common stock may be granted under the 2012 Equity Incentive Plan, and all options granted under this plan had exercise prices that were equal to the fair market value on the date of grant. During 2014, the Company granted options to purchase 15,292,914 shares, with total options outstanding of 28,815,899 as of December 31, 2014.

FASB ASC 718, Compensation – Stock Compensation, requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under ASC 718, Company is required to measure the cost of employee services received in exchange for stock options and similar awards based on the grant-date fair value of the award and recognize this cost in the income statement over the period during which an employee is required to provide service in exchange for the award. The Company recorded $1,219 and $525 for the years ended December 31, 2014 and 2013, respectively, of non-cash charges for stock compensation related to amortization of the fair value of restricted stock and unvested stock options. The total compensation costs related to non-vested awards not yet recognized were $3,090 and $487 for the years ended December 31, 2014 and 2013, respectively.

On August 3, 2010, in conjunction with an employment agreement with Thomas Steipp, the Company’s Chief Executive Officer, the Company also granted an aggregate of 6,000,000 restricted shares of the Company’s common stock, which will ratably vest each year over five years. During the years December 31, 2014 and 2013, the Company recorded $312 and $312, respectively, of compensation expense related to Mr. Steipp’s restricted shares.

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions noted in the following table.

	December 31,
	2014		2013

Expected volatility		157.24% - 179.87%		128.55% - 168.09%
Expected dividends		-		-
Expected term (in years)		5.50-7.50		6.32 - 9.61
Risk-free rate		1.65% - 2.22%		1.26% - 2.49%

Expected volatilities are based on historical volatility expected over the expected life of the options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. Forfeiture rates of 7.01% and 28.3% were used for options granted during the years ended December 31, 2014 and 2013, respectively. The risk free rate for period within the expected life of the options is based on U.S. Treasury rates in effect at the time of grant.

The following table summarizes the Company’s stock option transactions for the years ended December 31, 2014 and 2013:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
								(in thousands)
Options outstanding at December 31, 2012		3,722,000			0.36
Granted		13,317,500			0.08
Exercised		(600,000	)		0.12
Forfeited		(605,000	)		0.20
Expired		(100,000	)		2.49
Options outstanding at December 31, 2013		15,734,500			0.13
Granted		15,292,914			0.29
Exercised		(2,242,014	)		0.09
Forfeited		(1,219,501	)		0.20
Expired		(25,000	)		1.43
Options outstanding at December 31, 2014		27,540,899		$	0.21		8.3	$	450
Options exercisable at December 31, 2014		4,250,723		$	0.21		6.3	$	123
Options unvested at December 31, 2014		23,290,176		$	0.21		8.7	$	327
Options vested or expected to vest at December 31, 2014		22,593,015		$	0.22		8.3	$	327

The following table provides supplemental data on stock options for the years ended December 31, 2013 and 2014:

	December 31,
	2014		2013

Weighted average grant date fair value per option granted	$	0.28	$	0.08
Fair value of options vested		385		54
Cash from participants to exercise stock options		205		74
Intrinsic value of options exercised		385		22

The following table summarizes the Company’s stock options outstanding and exercisable by ranges of option prices as of December 31, 2014:

Options Outstanding								Options Exercisable
Range of Exercise Prices		Numbers of options Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price

$	0.00 - 0.10		10,444,985		8.11	$	0.08		2,849,723		8.11	$	0.08
	0.11 - 2.33		17,095,914		8.49		0.29		1,401,000		2.71		0.48

Total			27,540,899						4,250,723

The Company’s non-vested options at the beginning and ending of fiscal year 2014 had weighted-average grant-date fair values of $0.09 and $0.21 per option, respectively.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References+ Details

Note 15 - Income Taxes

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

15. Income Taxes

Significant components of deferred tax assets are as follows:

	Years Ended December 31,
	2014			2013

Loss carry forwards	$	53,310		$	50,165
Derivative valuations		(178	)		891
NQSO		1,111			628
Tax Credits		433			431
Other		272			259
Total deferred tax asset		54,948			52,374

Valuation allowance		(54,948	)		(52,374	)
Total deferred tax asset, net		-			-

The following table accounts for the differences between the expected federal tax benefit (based on the statutory U.S. federal income tax rate of 34%) and the actual tax provision:

	Years Ended December 31,
	2014			2013

Expected federal tax benefit		-34.0	%		-34.0	%
Permanent items		0.1	%		0.1	%
Net operating loss utilized or expired		0.0	%		0.0	%
Increase in valuation allowance and others		33.9	%		33.9	%
Total deferred tax asset		0	%		0	%

As of December 31, 2014, the Company had approximately $134.6M of net operating loss (“NOL”) carryforwards for U.S. federal income tax and state tax purposes expiring in 2018 through 2034, and 2015 through 2034, respectively. The Company and Liquidmetal Golf, Inc. filed on a separate company basis for federal income tax purposes. Accordingly, the federal NOL carryforwards of one legal entity are not available to offset federal taxable income of the other. Liquidmetal Golf, Inc. had approximately $35.9 in federal NOL carryforwards, expiring in 2018 through 2029.

We recognize excess tax benefits associated with the exercise of stock options directly to stockholders’ equity only when realized. Accordingly, deferred tax assets are not recognized for NOL carryforwards resulting from excess tax benefits. As of December 31, 2014, deferred tax assets do not include approximately $96 of these tax effected excess tax benefits from employee stock option exercise that are a component of our NOL carryforwards. Accordingly, additional paid-in capital will increase up to an additional $96 if and when such excess tax benefits are realized.

As of December 31, 2014, the Company had approximately $189 of Research & Development (“R&D”) credit carryforwards for U.S. federal income tax purposes expiring in 2021 through 2030. In addition, the Company has California R&D credit carryforwards of approximately $243, which do not expire under current California law.

Section 382 of the Internal Revenue Code (“IRC”) imposes limitations on the use of NOL’s and credits following changes in ownership as defined in the IRC. The limitation could reduce the amount of benefits that would be available to offset future taxable income each year, starting with the year of an ownership change. As a result of the completion of the complex analysis required by the IRC to determine if an ownership change has occurred, the Company has determined that its annual NOL carryforward limitation under Section 382 of the IRC is $764 per year.

The ability to realize the tax benefits associated with deferred tax assets, which includes benefits related to NOL’s, is principally dependent upon the Company’s ability to generate future taxable income from operations. The Company has provided a full valuation allowance for its net deferred tax assets due to the Company’s net operating losses.

The Company adopted the provisions of FASB ASC Topic 470 – Income Taxes. At the adoption date and as of December 31, 2014, the Company had no material unrecognized tax benefits and no adjustments to liabilities or operations were required. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense which were $0 for the year ended December 31, 2014 and 2013.

As of December 31, 2014, the tax years 2012 through 2013, and 2009 through 2013 are subject to examination by the federal and California taxing authorities, respectively.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References+ Details

Note 16 - Loss Per Common Share

12 Months Ended

Dec. 31, 2014

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

16. Loss Per Common Share

Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings.

Options to purchase 27,540,899 shares of common stock at prices ranging from $0.08 to $2.33 per share were outstanding at December 31, 2014, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 15,734,500 shares of common stock at prices ranging from $0.08 to $2.33 per share were outstanding at December 31, 2013, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

Warrants to purchase 66,057,792 shares of common stock, with prices ranging from $0.18 to $0.49 per share, outstanding at December 31, 2014 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 67,092,382 shares of common stock, with prices ranging from $0.18 to $0.49 per share, outstanding at December 31, 2013 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

- Definition

The entire disclosure for earnings per share.

+ References+ Details

Note 17 - Commitments and Contingencies

12 Months Ended

Dec. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

17. Commitments and Contingencies

Operating LeaseCommitments

The Company leases its offices and warehouse facilities under various lease agreements, certain of which are subject to escalations based upon increases in specified operating expenses or increases in the Consumer Price Index. As of December 31, 2014 and 2013, the Company has recorded $43 and $39, respectively, of deferred rent expenses. Future minimum lease payments under non-cancelable operating leases during subsequent years are as follows:

December 31,	Minimum Payments

2015		197
2016		206
2017		212
2018		217
2019		242
Thereafter		847
Total	$	1,921

Rent expense was $204 and $200 for the years ended December 31, 2014 and 2013, respectively.

- Definition

The entire disclosure for commitments and contingencies.

+ References+ Details

Note 18 - 401(k) Savings Plan

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

Pension and Other Postretirement Benefits Disclosure [Text Block]

18. 401(k) Savings Plan

The Company has a tax-qualified employee savings and retirement plan, or 401(k) plan. Under the 401 (k) plan, participants may elect to reduce their current compensation, on a pre-tax basis, by up to 15% of their taxable compensation or of the statutorily prescribed annual limit, whichever is lower, and have the amount of the reduction contributed to the 401(k) plan. The 401(k) plan permits the Company, in its sole discretion, to make additional employer contributions to the 401(k) plan. However, the Company did not make employer contributions to the 401(k) plan during any of the periods presented in the accompanying consolidated financial statements.

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References+ Details

Note 19 - Related Party Transactions

12 Months Ended

Dec. 31, 2014

19. Related Party Transactions

The Company entered into a license agreement (the “IMG License Agreement”) with Innovative Materials Group, LLC (“IMG”), a California limited liability company which is majority owned by Mr. John Kang, a former Chief Executive Officer and former Chairman of the Company, to license certain patents and technical information for the limited purpose of manufacturing certain licensed products with the Company’s first generation die cast machines. The IMG License Agreement granted a non-exclusive license to certain product categories and obligated IMG to pay the Company a running royalty based on its sales of licensed products through August 5, 2021. The Company recognized $6 and $8 in royalty revenues from IMG during years ended December 31, 2014 and December 31, 2013, respectively.

In February 2013, Mr. Abdi Mahamedi, the Company’s Chairman, converted his 58,600 shares of Series A-1 Preferred Stock and 260,710 shares of Series A-2 Preferred Stock into a total of 10,387,883 shares of the Company’s common stock, including dividends received in the form of common stock.

Mr. Thomas Steipp, the Company’s Chief Executive Officer, sold an aggregate of 400,000 shares of the common stock of the Company on August 5, 2013 pursuant to a trading plan that Mr. Steipp previously adopted under SEC Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Mr. Steipp adopted the trading plan on March 22, 2013 for the purpose of providing him with funds to satisfy certain tax liabilities as a result of the vesting on August 3, 2013 of 1,200,000 shares of Company restricted common stock held by Mr. Steipp. The restricted shares were granted to Mr. Steipp in 2010 under a previously disclosed Restricted Stock Award Agreement, dated August 3, 2010, between Mr. Steipp and the Company. On March 27, 2014, Mr. Steipp adopted a new SEC Rule 10b5-1 trading plan that allowed for the sale of 500,000 shares of common stock of the Company on August 4, 2014, and will allow for future sales of 500,000 shares of common stock of the Company on August 4, 2015.

In September 2013, the Company entered into Change of Control Agreements with Ricardo A. Salas, the Company’s Executive Vice-President, Tony Chung, the Company’s Chief Financial Officer, and certain other executive officers who are not named executive officers of the Company for SEC reporting purposes. The Change of Control Agreements provide that if the executive officer’s employment with the Company is terminated without cause during the one-year period after a change of control of the Company, then the terminated officer will receive lump sum severance compensation in an amount equal to twelve months of his then-current base salary. Under the agreements, each of the executive officers will also be entitled to the above-described severance compensation in the event he terminates his own employment within one year after a change of control because of a salary decrease or assignment to a lower-level position. In addition, upon termination, all unvested stock options related to these officers will automatically and immediately vest and shall thereafter be exercisable in accordance with the terms and provisions of the applicable award agreements.

The Company has an exclusive license agreement with LLPG, Inc. (“LLPG”), a corporation owned principally by Jack Chitayat, a former director of the Company. Under the terms of the agreement, LLPG has the right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021. There were no revenues recognized from product sales and licensing fees from LLPG during the years ended December 31, 2014 or 2013.

On February 27, 2013, Mr. Chitayat converted his 28,928 shares of Series A-1 Preferred Stock and 109,528 shares of Series A-2 Preferred Stock into a total of 4,626,840 shares of the Company’s common stock, including dividends received in the form of common stock.

On June 1, 2012, the Company entered into the Visser MTA relating to a strategic transaction for manufacturing services and financing. In November 2013, the Company and Visser entered into arbitration proceedings to resolve disputes associated with this agreement. As part of the May 2014 settlement of these proceedings, the Company has granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014, for all fields of use other than certain excluded fields as set forth therein. Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date of the agreement. The license to the Company’s intellectual property does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement entered into in connection with the settlement (see note 3). As of December 31, 2014, Visser is a greater-than-5% beneficial owner of the Company.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References+ Details

Note 20 - Subsequent Events

12 Months Ended

Dec. 31, 2014

Subsequent Events [Abstract]

Subsequent Events [Text Block]

20. Subsequent Events

2015 Equity Incentive Plan

On January 27, 2015, the Company adopted the 2015 Equity Incentive Plan (“2015 Plan”), which provides for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. The 2015 Plan provides for the granting to employees of incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, and for the granting to employees and consultants of non-statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of forty million shares of the Company’s common stock may be granted under the 2015 Plan, and all options granted under this plan had exercise prices that were equal to the fair market value on the date of grant. The 2015 Plan is pending approval of the Company’s shareholders, which will be subject to vote at the 2015 Annual Shareholders’ Meeting.

Line of Credit Facility

On February 24, 2015, the Company entered into a $2,000 line of credit facility with a commercial banking relationship. The Company may utilize the facility at any time for general business purposes. The facility will be fully secured with deposits held at the counterparty.

Accounting Policies, by Policy (Policies)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]

Revenue Recognition, Policy [Policy Text Block]

Cash and Cash Equivalents, Policy [Policy Text Block]

Receivables, Policy [Policy Text Block]

Property, Plant and Equipment, Policy [Policy Text Block]

Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Fair Value Measurement, Policy [Policy Text Block]

Level 1 —

Quoted prices in active markets for identical assets or liabilities;

Level 2 —

Level 3 —

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

As of December 31, 2014, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities		-		-		2,005		-

As of December 31, 2013, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities		-		-		4,921		-

Research and Development Expense, Policy [Policy Text Block]

Advertising Costs, Policy [Policy Text Block]

Legal Costs, Policy [Policy Text Block]

Legal Costs. Legal costs are expensed as incurred.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Income Tax, Policy [Policy Text Block]

Earnings Per Share, Policy [Policy Text Block]

Use of Estimates, Policy [Policy Text Block]

Subsequent Events, Policy [Policy Text Block]

Subsequent Events. The Company evaluated subsequent events through the filing of its Annual Report on Form 10-K with the SEC.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements.

Presentation of Unrecognized Tax Benefits

Revenue from Contracts with Customers

Ability to Continue as a Going Concern

Note 2 - Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities		-		-		2,005		-

	Fair Value		Level 1		Level 2		Level 3

Warrant liabilities		-		-		4,921		-

Note 5 - Trade Accounts Receivable (Tables)

12 Months Ended

Dec. 31, 2014

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

	December 31,
	2014		2013
Trade accounts receivable	$	83	$	215
Less: Allowance for doubtful accounts		-		-
Trade accounts receivable, net	$	83	$	215

Note 7 - Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2014

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

	December 31,
	2014			2013

Machinery and equipment	$	1,903		$	1,107
Computer equipment		218			203
Office equipment, furnishings, and improvements		531			277
Total		2,652			1,587
Accumulated depreciation		(1,534	)		(1,338	)
Total property and equipment, net	$	1,118		$	249

Note 8 - Patents and Trademarks, Net (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	December 31,
	2014			2013

Purchased and licensed patent rights	$	566		$	566
Internally developed patents		1,664			1,664
Trademarks		148			139
Total		2,378			2,369
Accumulated amortization	$	(1,709	)	$	(1,605	)
Total intangible assets, net	$	669		$	764

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

December 31,	Aggregate Amortization Expense
2015		99
2016		97
2017		85
2018		85
2019		82
Thereafter		221
	$	669

Finite-Lived Intangible Assets Accumulated Amortization [Table Text Block]

	December 31,
	2014			2013

Purchased and licensed patent rights	$	(500	)	$	(483	)
Internally developed patents		(1,103	)		(1,022	)
Trademarks		(106	)		(100	)
Total	$	(1,709	)	$	(1,605	)

Finite-Lived Intangible Assets Weighted Average Amortization Periods [Table Text Block]

	December 31,
	2014		2013

Purchased and licensed patent rights		17		17
Internally developed patents		17		17
Trademarks		10		10

Note 12 - Warrant Liabilities (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

	Visser MTA			July 2, 2012
	Agreement			Private Placement			Total

Beginning Balance - December 31, 2013	$	2,559		$	2,362			4,921
Change in value of warrant liability, gain	$	(1,506	)	$	(1,194	)		(2,700	)
Reclassification to equity upon warrant exercise		-			(216	)		(216	)
Ending Balance - December 31, 2014	$	1,053		$	952		$	2,005

Fair Value Assumptions Used for Warrants Outstanding [Table Text Block]

	December 31,
	2014		2013
Expected life in years		2.42 - 2.50		3.42 - 3.50
Volatility		96% - 97%		142% - 143%
Risk-free interest rate		1.10%		1.75%
Dividend rate		0%		0%

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Number of Shares		Exercise Price		Expiration Date

	208,334	$	0.480	July 15, 2015
	29,571,223	$	0.490	July 15, 2015
	18,706,235	$	0.176	June 1, 2017
	17,572,000	$	0.192	July 2, 2017
	66,057,792

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details

Note 14 - Stock Compensation Plan (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	December 31,
	2014		2013

Expected volatility		157.24% - 179.87%		128.55% - 168.09%
Expected dividends		-		-
Expected term (in years)		5.50-7.50		6.32 - 9.61
Risk-free rate		1.65% - 2.22%		1.26% - 2.49%

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
								(in thousands)
Options outstanding at December 31, 2012		3,722,000			0.36
Granted		13,317,500			0.08
Exercised		(600,000	)		0.12
Forfeited		(605,000	)		0.20
Expired		(100,000	)		2.49
Options outstanding at December 31, 2013		15,734,500			0.13
Granted		15,292,914			0.29
Exercised		(2,242,014	)		0.09
Forfeited		(1,219,501	)		0.20
Expired		(25,000	)		1.43
Options outstanding at December 31, 2014		27,540,899		$	0.21		8.3	$	450
Options exercisable at December 31, 2014		4,250,723		$	0.21		6.3	$	123
Options unvested at December 31, 2014		23,290,176		$	0.21		8.7	$	327
Options vested or expected to vest at December 31, 2014		22,593,015		$	0.22		8.3	$	327

Schedule of Supplemental Stock Option Data [Table Text Block]

	December 31,
	2014		2013

Weighted average grant date fair value per option granted	$	0.28	$	0.08
Fair value of options vested		385		54
Cash from participants to exercise stock options		205		74
Intrinsic value of options exercised		385		22

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Options Outstanding								Options Exercisable
Range of Exercise Prices		Numbers of options Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price

$	0.00 - 0.10		10,444,985		8.11	$	0.08		2,849,723		8.11	$	0.08
	0.11 - 2.33		17,095,914		8.49		0.29		1,401,000		2.71		0.48

Total			27,540,899						4,250,723

Note 15 - Income Taxes (Tables)

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	Years Ended December 31,
	2014			2013

Loss carry forwards	$	53,310		$	50,165
Derivative valuations		(178	)		891
NQSO		1,111			628
Tax Credits		433			431
Other		272			259
Total deferred tax asset		54,948			52,374

Valuation allowance		(54,948	)		(52,374	)
Total deferred tax asset, net		-			-

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	Years Ended December 31,
	2014			2013

Expected federal tax benefit		-34.0	%		-34.0	%
Permanent items		0.1	%		0.1	%
Net operating loss utilized or expired		0.0	%		0.0	%
Increase in valuation allowance and others		33.9	%		33.9	%
Total deferred tax asset		0	%		0	%

Note 17 - Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

December 31,	Minimum Payments

2015		197
2016		206
2017		212
2018		217
2019		242
Thereafter		847
Total	$	1,921

Note 2 - Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Accounts Receivable, Gross, Current (in Dollars)	$ 83,000	$ 215,000
Embedded Derivative, Fair Value of Embedded Derivative Liability (in Dollars)	0
Advertising Expense (in Dollars)	252,000	78,000
Trade Accounts Receivable [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage	100.00%	99.00%
Accounts Receivable, Gross, Current (in Dollars)	$ 83,000	$ 212,000
Sales Revenue, Goods, Net [Member] \| Customer Concentration Risk [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk Number of Major Customers	2	3
Concentration Risk, Percentage	84.00%	80.00%
Minimum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	1 year
Finite-Lived Intangible Asset, Useful Life	10 years
Maximum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Finite-Lived Intangible Asset, Useful Life	17 years

Note 3 - Significant Transactions (Details) (USD $) In Thousands, except Share data, unless otherwise specified	1 Months Ended	12 Months Ended				1 Months Ended						1 Months Ended				1 Months Ended	0 Months Ended	12 Months Ended			1 Months Ended	0 Months Ended
	Jul. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2012 Visser MTA Agreement [Member] Private Placement [Member] Convertible Notes Payable [Member]	Dec. 31, 2014 Visser MTA Agreement [Member] Private Placement [Member] Additional Warrants for Anti-dilution Impact [Member]	Jun. 30, 2012 Visser MTA Agreement [Member] Private Placement [Member]	Dec. 31, 2014 Visser MTA Agreement [Member] Private Placement [Member]	Aug. 20, 2014 The 2014 Purchase Agreement [Member] Regular Purchase Notice [Member] Maximum [Member]	Aug. 20, 2014 The 2014 Purchase Agreement [Member] Regular Purchase Notice [Member]	Aug. 20, 2014 The 2014 Purchase Agreement [Member] Regular Purchase Notice with Minimum Purchase Price Per Share [Member]	Aug. 20, 2014 The 2014 Purchase Agreement [Member] Minimum [Member]	Aug. 20, 2014 The 2014 Purchase Agreement [Member]	Sep. 09, 2014 The 2014 Purchase Agreement [Member]	Nov. 08, 2013 Common Stock Purchase Agreement [Member] After Sale of Shares Pursuant to Draw Down Notice [Member]	Dec. 31, 2014 Common Stock Purchase Agreement [Member] Weighted Average [Member]	Aug. 20, 2014 Common Stock Purchase Agreement [Member]	Nov. 08, 2013 Common Stock Purchase Agreement [Member]	Dec. 31, 2014 Common Stock Purchase Agreement [Member]	Feb. 11, 2014 Common Stock Purchase Agreement [Member]	Jul. 31, 2012 Private Placement [Member] Warrants Part of Additional Paid in Capital [Member] Convertible Notes Payable [Member] Amended Agreement [Member]	Jul. 31, 2012 Private Placement [Member] Warrants Part of Additional Paid in Capital [Member] Convertible Notes Payable [Member]	Jul. 02, 2012 Private Placement [Member] Convertible Notes Payable [Member]	Jul. 31, 2013 Private Placement [Member] Weighted Average [Member]	Dec. 31, 2014 Private Placement [Member]	Jul. 17, 2013 Private Placement [Member]	Jul. 02, 2012 Private Placement [Member]	Jul. 31, 2013 Convertible Notes Payable [Member]	Dec. 31, 2014 Maximum [Member]	Dec. 31, 2014 Minimum [Member]	Dec. 31, 2014 Liquidmetal Golf [Member]
Note 3 - Significant Transactions (Details) [Line Items]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors (in Dollars)								$ 400				$ 30,000				$ 30,000	$ 20,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)		$ 0.001	$ 0.001									$ 0.001					$ 0.001
Common Stock Subscriptions Term												36 months				3 years	36 months
Common Stock, Capital Shares Reserved for Future Issuance									1,000,000	500,000
Share Price (in Dollars per share)										$ 0.30	$ 0.10				$ 0.19
Common Stock Shares Covered by Registration Statement													75,000,000						96,555,893
Stock Issued During Period, Shares, Other																	2,666,667
Subscription Multiplier for Price Floor																	0.775
Subscription Floor Price (in Dollars per share)																	$ 0.03875
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners														9.99%
Stock Issued During Period, Value, New Issues (in Dollars)		16,000	12,253															16,000
Stock Issued During Period, Shares, New Issues						30,000,000												85,355,615
Debt Instrument, Face Amount (in Dollars)				2,000																		12,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																						$ 0.352	$ 0.0774				$ 0.0774
Debt Instrument, Interest Rate, Stated Percentage																						8.00%
Senior Convertible Notes Arithmetic Average, Percentage																					87.50%	87.50%
Trading Days																					20 days	20 days
Trading Day Preceding Reset, Date	2 years																					2 days
Common Stock, Shares, Issued		464,482,819	375,707,190																						163,641,547
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		29,779,557	29,779,557		18,706,235	15,000,000	18,611,079														18,750,000					18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)						$ 0.22														$ 0.19	$ 0.384			$ 0.19		$ 0.384		$ 0.49	$ 0.48
Sale of Stock, Price Per Share (in Dollars per share)						$ 0.10
Proceeds from Issuance of Common Stock (in Dollars)		$ 16,000				$ 3,000
Class of Warrant or Right, Adjusted Exercise Price of Warrants or Rights (in Dollars per Share)							$ 0.18
Noncontrolling Interest, Ownership Percentage by Parent																														79.00%

Note 4 - Liquidity and Going Concern Issues (Details) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended				1 Months Ended	0 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014 Common Stock Purchase Agreement [Member] Weighted Average [Member]	Aug. 20, 2014 Common Stock Purchase Agreement [Member]	Nov. 08, 2013 Common Stock Purchase Agreement [Member]	Dec. 31, 2014 Common Stock Purchase Agreement [Member]
Note 4 - Liquidity and Going Concern Issues (Details) [Line Items]
Net Cash Provided by (Used in) Operating Activities	$ (7,419)	$ (4,977)
Net Cash Provided by (Used in) Investing Activities	(1,065)	(197)
Net Cash Provided by (Used in) Financing Activities	16,431	74
Cash and Cash Equivalents, at Carrying Value	10,009	2,062	7,162
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors					30,000	20,000
Common Stock Subscriptions Term					3 years	36 months
Stock Issued During Period, Value, New Issues	$ 16,000	$ 12,253					$ 16,000
Stock Issued During Period, Shares, New Issues (in Shares)							85,355,615
Share Price (in Dollars per share)				$ 0.19

Note 5 - Trade Accounts Receivable (Details) - Trade Acounts Receivable Table (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Trade Acounts Receivable Table [Abstract]
Trade accounts receivable	$ 83	$ 215
Trade accounts receivable, net	$ 83	$ 215

Note 7 - Property and Equipment (Details) - Property and Equipment (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, plant, and equipment gross	$ 2,652	$ 1,587
Accumulated depreciation	(1,534)	(1,338)
Total property and equipment, net	1,118	249
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment gross	1,903	1,107
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment gross	218	203
Office Equipment Furnishings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment gross	$ 531	$ 277

Note 8 - Patents and Trademarks, Net (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Disclosure Text Block [Abstract]
Amortization of Intangible Assets	$ 104	$ 118

Note 8 - Patents and Trademarks, Net (Details) - Patents and Trademarks (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Finite lived intangible assets, gross	$ 2,378	$ 2,369
Accumulated amortization	(1,709)	(1,605)
Total intangible assets, net	669	764
Purchased and Licensed Patent Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Finite lived intangible assets, gross	566	566
Accumulated amortization	(500)	(483)
Internally Developed Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite lived intangible assets, gross	1,664	1,664
Accumulated amortization	(1,103)	(1,022)
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Finite lived intangible assets, gross	148	139
Accumulated amortization	$ (106)	$ (100)

Note 8 - Patents and Trademarks, Net (Details) - Estimated Future Aggregate Amortization Expense (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Estimated Future Aggregate Amortization Expense [Abstract]
2015	$ 99
2016	97
2017	85
2018	85
2019	82
Thereafter	221
	$ 669	$ 764

Note 9 - Accrued Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Payables and Accruals [Abstract]
Accrued Liabilities, Current	$ 705	$ 710
Employee-related Liabilities, Current	567	511
Accrued Professional Fees, Current	95	67
Accrued Rent, Current	43	39
Accrued Insurance, Current		$ 93

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References+ Details

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References+ Details

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References+ Details

Note 10 - Other Long-term Liabilities (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]
Other Liabilities, Noncurrent	$ 856	$ 856
Period for Outstanding Liability	5 years

Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Details) (USD $) In Thousands, except Share data, unless otherwise specified	1 Months Ended	0 Months Ended	12 Months Ended			13 Months Ended		1 Months Ended	12 Months Ended
	Jul. 17, 2013	Jul. 02, 2012	Dec. 31, 2013	Dec. 31, 2014	Jul. 02, 2012 Private Placement [Member] Convertible Notes Payable [Member]	Jul. 31, 2013 Private Placement [Member]	Jul. 02, 2012 Private Placement [Member]	Jul. 31, 2013 Convertible Notes Payable [Member]	Dec. 31, 2014 Convertible Notes Payable [Member]	Dec. 31, 2013 Convertible Notes Payable [Member]
Note 11 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Details) [Line Items]
Debt Instrument, Face Amount					$ 12,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)					$ 0.352			$ 0.0774
Debt Instrument, Interest Rate, Stated Percentage					8.00%
Embedded Derivatives, Addition, Original Valuation							8,865
Warrants and Rights Outstanding			18,179	18,179			5,053
Embedded Conversion Feature Liability and Warrants							13,918
Debt Instrument, Unamortized Discount		12,000
Change in face value of the embedded conversion feature liability and warrants		1,918
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	18,679,584					163,641,547
Gains (Losses) on Extinguishment of Debt	91		91
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)								163,641,547
Debt Instrument, Periodic Payment, Principal								12,000
Debt Instrument, Periodic Payment, Interest								680
Interest Expense, Debt									$ 0	$ 242

Note 12 - Warrant Liabilities (Details) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended			0 Months Ended	12 Months Ended				12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 30, 2013	Jul. 08, 2014 Private Placement [Member]	Dec. 31, 2014 Private Placement [Member]	Dec. 31, 2013 Private Placement [Member]	Dec. 30, 2013 Private Placement [Member]	Jul. 02, 2012 Private Placement [Member]	Dec. 31, 2014 Visser MTA Agreement [Member]	Dec. 31, 2013 Visser MTA Agreement [Member]	Jun. 30, 2012 Visser MTA Agreement [Member]	Dec. 31, 2014 Warrants Valued As Liability [Member]	Dec. 31, 2013 Warrants Valued As Liability [Member]
Note 12 - Warrant Liabilities (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	29,779,557	29,779,557						18,750,000	18,706,235	18,562,825	15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)					$ 0.19			$ 0.384	$ 0.18	$ 0.18	$ 0.22
Derivative Liability, Noncurrent	$ 2,005	$ 4,921	$ 4,921		$ 952		$ 2,362	$ 5,053	$ 1,053		$ 4,260
Fair Value Assumptions, Expected Term					2 years 6 months				2 years 153 days
Fair Value Assumptions, Expected Volatility Rate					96.00%				97.00%
Fair Value Assumptions, Risk Free Interest Rate	1.10%	1.75%			1.10%				1.10%
Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%			0.00%				0.00%
Fair Value Adjustment of Warrants	(2,700)	2,155			(1,194)	856			(1,506)	1,299
(in Shares)				1,178,000
Investment Warrants, Exercise Price (in Dollars per share)				$ 0.19
Proceeds from Warrant Exercises	226			226
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt	216			216	216
Class of Warrant or Right, Outstanding (in Shares)	66,057,792	67,092,382										36,278,235	37,312,825
Warrants and Rights Outstanding	$ 18,179	$ 18,179						$ 5,053				$ 2,005	$ 4,921

Note 12 - Warrant Liabilities (Details) - Warrant Liability Activity (USD $) In Thousands, unless otherwise specified	0 Months Ended	12 Months Ended
	Jul. 08, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 30, 2013	Jul. 02, 2012
Note 12 - Warrant Liabilities (Details) - Warrant Liability Activity [Line Items]
Beginning Balance - December 31, 2013		$ 4,921		$ 4,921
Change in value of warrant liability, gain		(2,700)	2,155
Reclassification to equity upon warrant exercise		(216)
Ending Balance - December 31, 2014		2,005	4,921	4,921
Visser MTA Agreement [Member]
Note 12 - Warrant Liabilities (Details) - Warrant Liability Activity [Line Items]
Beginning Balance - December 31, 2013				2,559
Change in value of warrant liability, gain		(1,506)
Ending Balance - December 31, 2014		1,053		2,559
Private Placement [Member]
Note 12 - Warrant Liabilities (Details) - Warrant Liability Activity [Line Items]
Beginning Balance - December 31, 2013				2,362	5,053
Change in value of warrant liability, gain		(1,194)	856
Reclassification to equity upon warrant exercise	(216)	(216)
Ending Balance - December 31, 2014		$ 952		$ 2,362	$ 5,053

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.

+ References+ Details

Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding [Line Items]
Risk-free interest rate	1.10%	1.75%
Dividend rate	0.00%	0.00%
Minimum [Member]
Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding [Line Items]
Expected life in years	2 years 153 days	3 years 153 days
Volatility	96.00%	142.00%
Maximum [Member]
Note 12 - Warrant Liabilities (Details) - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding [Line Items]
Expected life in years	2 years 6 months	3 years 6 months
Volatility	97.00%	143.00%

Note 12 - Warrant Liabilities (Details) - Outstanding Warrants to Acquire Shares of the Common Stock (USD $)			12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014 Warrant 1 [Member]	Dec. 31, 2014 Warrant 2 [Member]	Dec. 31, 2014 Warrant 3 [Member]	Dec. 31, 2014 Warrant 4 [Member]
Class of Warrant or Right [Line Items]
Number of shares	66,057,792	67,092,382	208,334	29,571,223	18,706,235	17,572,000
Exercise price (in Dollars per share)			$ 0.480	$ 0.490	$ 0.176	$ 0.192
Expiration date			Jul. 15, 2015	Jul. 15, 2015	Jun. 01, 2017	Jul. 02, 2017

Note 13 - Shareholders' Equity (Deficit) (Details) (USD $)	1 Months Ended	12 Months Ended						12 Months Ended		0 Months Ended	1 Months Ended			0 Months Ended				13 Months Ended		1 Months Ended	13 Months Ended				0 Months Ended	12 Months Ended
	Jul. 17, 2013	Dec. 31, 2014	Dec. 31, 2013	Oct. 24, 2013	Feb. 28, 2013	Feb. 27, 2013	Dec. 31, 2012	Dec. 31, 2013 Series A Preferred Stock [Member]	Dec. 31, 2012 Series A Preferred Stock [Member]	May 01, 2009 Convertible Series A1 Preferred Stock [Member]	Oct. 31, 2009 Convertible Series A1 Preferred Stock [Member]	Dec. 31, 2012 Convertible Series A1 Preferred Stock [Member]	May 02, 2009 Convertible Series A1 Preferred Stock [Member]	May 01, 2009 Convertible Series A2 Preferred Stock [Member]	Dec. 31, 2012 Convertible Series A2 Preferred Stock [Member]	Oct. 31, 2009 Convertible Series A2 Preferred Stock [Member]	May 02, 2009 Convertible Series A2 Preferred Stock [Member]	Jul. 31, 2013 Private Placement [Member] Senior Convertible Notes [Member]	Jul. 31, 2013 Private Placement [Member] Weighted Average [Member]	Jun. 30, 2012 Private Placement [Member] Visser MTA Agreement [Member]	Jul. 31, 2013 Private Placement [Member]	Dec. 31, 2014 Private Placement [Member]	Jul. 02, 2012 Private Placement [Member]	Dec. 31, 2014 Common Stock Purchase Agreement [Member] Weighted Average [Member]	Nov. 08, 2013 Common Stock Purchase Agreement [Member]	Dec. 31, 2014 Common Stock Purchase Agreement [Member]	Dec. 31, 2014 Common Stock [Member]	Dec. 31, 2013 Common Stock [Member]	Dec. 31, 2012 Common Stock [Member]	Dec. 31, 2014 Minimum [Member]	Dec. 31, 2014 Maximum [Member]
Note 13 - Shareholders' Equity (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues										500,000										30,000,000						85,355,615	85,355,615	116,136,796
Debt Conversion, Converted Instrument, Shares Issued	18,679,584																				163,641,547
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																			$ 0.0774
Debt Instrument, Periodic Payment, Principal (in Dollars)																		$ 12,000,000
Debt Instrument, Periodic Payment, Interest (in Dollars)																		680,000
Conversion of Stock, Shares Converted								506,936	792,215
Conversion of Stock, Shares Issued																												16,896,070
Common Stock, Shares Authorized		700,000,000	700,000,000	700,000,000	500,000,000	400,000,000
Stock Issued During Period, Shares, Other											180,000			2,625,000											2,666,667
Stock Issued During Period, Value, New Issues (in Dollars)		16,000,000	12,253,000																							16,000,000	85,000	116,000
Share Price (in Dollars per share)													$ 5.00				$ 5.00							$ 0.19
Convertible Preferred Stock, Conversion Price (in Dollars per share)											$ 0.10					$ 0.22
Convertible Preferred Stock, Shares Issued upon Conversion			16,896,070																										25,669,752
Preferred Stock, Shares Outstanding		0	0						506,936			105,231			401,705
Preferred Stock, Value, Issued (in Dollars)		0	0				0
Dividends Payable (in Dollars)									222,000
Adjustments to Additional Paid in Capital, Reclassification of Accrued Preferred Stock Dividends (in Dollars)			222,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		29,779,557	29,779,557																				18,750,000
Warrants and Rights Outstanding (in Dollars)		$ 18,179,000	$ 18,179,000																				$ 5,053,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																						$ 0.19	$ 0.384							$ 0.48	$ 0.49

Note 14 - Stock Compensation Plan (Details) (USD $)	12 Months Ended			12 Months Ended	0 Months Ended
Note 14 - Stock Compensation Plan (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014 Employee Stock Option [Member] Equity Incentive Plan 2012 [Member]	Aug. 03, 2010 Restricted Stock [Member] Chief Executive Officer [Member]	Dec. 31, 2014 2002 Equity Incentive Plan [Member]	Dec. 31, 2014 Equity Incentive Plan 2012 [Member]
Note 14 - Stock Compensation Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	27,540,899	15,734,500	3,722,000	28,815,899		1,725,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized							30,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	15,292,914	13,317,500		15,292,914
Allocated Share-based Compensation Expense	$ 1,219	$ 525
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	3,090	487
Deferred Compensation Arrangement with Individual, Shares Issued					6,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					5 years
Deferred Compensation Arrangement with Individual, Compensation Expense	$ 312,000	$ 312,000
Share-based Compensation Arrangement by Share-based Payment Award Fair Value Assumptions Forfeiture Rates, Minimum	7.01%	28.30%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value	$ 0.09	$ 0.21

Note 14 - Stock Compensation Plan (Details) - Assumptions Used to Estimate Fair Value	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Minimum [Member]
Note 14 - Stock Compensation Plan (Details) - Assumptions Used to Estimate Fair Value [Line Items]
Expected volatility	157.24%	128.55%
Expected term (in years)	5 years 6 months	6 years 116 days
Risk-free rate	1.65%	1.26%
Maximum [Member]
Note 14 - Stock Compensation Plan (Details) - Assumptions Used to Estimate Fair Value [Line Items]
Expected volatility	179.87%	168.09%
Expected term (in years)	7 years 6 months	9 years 222 days
Risk-free rate	2.22%	2.49%

Note 14 - Stock Compensation Plan (Details) - Summary of Stock Option Transactions (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Summary of Stock Option Transactions [Abstract]
Options outstanding	27,540,899	15,734,500	3,722,000
Options outstanding	$ 0.21	$ 0.13	$ 0.36
Options outstanding	8 years 109 days
Options outstanding	$ 450
Granted	15,292,914	13,317,500
Granted	$ 0.29	$ 0.08
Exercised	(2,242,014)	(600,000)
Exercised	$ 0.09	$ 0.12
Forfeited	(1,219,501)	(605,000)
Forfeited	$ 0.20	$ 0.20
Expired	(25,000)	(100,000)
Expired	$ 1.43	$ 2.49
Options exercisable at December 31, 2014	4,250,723
Options exercisable at December 31, 2014	$ 0.21
Options exercisable at December 31, 2014	6 years 109 days
Options exercisable at December 31, 2014	123
Options unvested at December 31, 2014	23,290,176
Options unvested at December 31, 2014	$ 0.21
Options unvested at December 31, 2014	8 years 255 days
Options unvested at December 31, 2014	327
Options vested or expected to vest at December 31, 2014	22,593,015
Options vested or expected to vest at December 31, 2014	$ 0.22
Options vested or expected to vest at December 31, 2014	8 years 109 days
Options vested or expected to vest at December 31, 2014	$ 327

Note 14 - Stock Compensation Plan (Details) - Supplemental Stock Option Information (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Supplemental Stock Option Information [Abstract]
Weighted average grant date fair value per option granted (in Dollars per share)	$ 0.28	$ 0.08
Fair value of options vested	$ 385	$ 54
Cash from participants to exercise stock options	205	74
Intrinsic value of options exercised	$ 385	$ 22

Note 14 - Stock Compensation Plan (Details) - Summary of Stock Options Outstanding and Exercisable by Ranges of Option Prices (USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options oustanding (in Shares)	27,540,899
Number of options exercisable (in Shares)	4,250,723
Range $0.00 - 0.10 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise prices lower range	$ 0.00
Range of exercise prices upper range	$ 0.10
Number of options oustanding (in Shares)	10,444,985
Weighted average remaining contractual life	8 years 40 days
Weighted average exercise price	$ 0.08
Number of options exercisable (in Shares)	2,849,723
Weighted average remaining contractual life	8 years 40 days
Weighted average exercise price	$ 0.08
Range $0.11 - 2.33 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise prices lower range	$ 0.11
Range of exercise prices upper range	$ 2.33
Number of options oustanding (in Shares)	17,095,914
Weighted average remaining contractual life	8 years 178 days
Weighted average exercise price	$ 0.29
Number of options exercisable (in Shares)	1,401,000
Weighted average remaining contractual life	2 years 259 days
Weighted average exercise price	$ 0.48

Note 15 - Income Taxes (Details) (USD $)	12 Months Ended
Note 15 - Income Taxes (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Note 15 - Income Taxes (Details) [Line Items]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%
Adjustments to Additional Paid in Capital, Share-based Compensation and Exercise of Stock Options	$ 96,000
Net Operating Loss Carryforward Limitation	764,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	0	0
Liquidmetal Golf Inc [Member] \| Domestic Tax Authority [Member]
Note 15 - Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	35,900
Domestic Tax Authority [Member] \| Research Tax Credit Carryforward [Member]
Note 15 - Income Taxes (Details) [Line Items]
Tax Credit Carryforward, Amount	189,000
Domestic Tax Authority [Member]
Note 15 - Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	134,000,000
State and Local Jurisdiction [Member] \| Research Tax Credit Carryforward [Member]
Note 15 - Income Taxes (Details) [Line Items]
Tax Credit Carryforward, Amount		243,000
Employee Stock Option [Member]
Note 15 - Income Taxes (Details) [Line Items]
Unrecognized Tax Benefits	$ 96,000

Note 15 - Income Taxes (Details) - Significant Components of Deferred Tax Assets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Significant Components of Deferred Tax Assets [Abstract]
Loss carry forwards	$ 53,310	$ 50,165
Derivative valuations	(178)	891
NQSO	1,111	628
Tax Credits	433	431
Other	272	259
Total deferred tax asset	54,948	52,374
Valuation allowance	$ (54,948)	$ (52,374)

Note 15 - Income Taxes (Details) - Differences Between the Expected Federal Tax Benefit and Actual Tax Provision	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Differences Between the Expected Federal Tax Benefit and Actual Tax Provision [Abstract]
Expected federal tax benefit	(34.00%)	(34.00%)
Permanent items	0.10%	0.10%
Net operating loss utilized or expired	0.00%	0.00%
Increase in valuation allowance and others	33.90%	33.90%
Total deferred tax asset	0.00%	0.00%

- Definition

Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deductions. Including, but not limited to, extraterritorial income exclusion deduction, qualified production activity deduction, dividend deduction, deduction for dividend paid to employee stock ownership plan, Medicare prescription drug benefit subsidy deduction, and other deductions.

+ References+ Details

Note 16 - Loss Per Common Share (Details) (USD $)								12 Months Ended						12 Months Ended
Note 16 - Loss Per Common Share (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014 Equity Option [Member] Minimum [Member]	Dec. 31, 2013 Equity Option [Member] Minimum [Member]	Dec. 31, 2014 Equity Option [Member] Maximum [Member]	Dec. 31, 2013 Equity Option [Member] Maximum [Member]	Dec. 31, 2014 Equity Option [Member]	Dec. 31, 2013 Equity Option [Member]	Dec. 31, 2014 Warrant [Member] Minimum [Member]	Dec. 31, 2013 Warrant [Member] Minimum [Member]	Dec. 31, 2014 Warrant [Member] Maximum [Member]	Dec. 31, 2013 Warrant [Member] Maximum [Member]	Dec. 31, 2014 Warrant [Member]	Dec. 31, 2013 Warrant [Member]	Dec. 31, 2014 Minimum [Member]	Dec. 31, 2014 Maximum [Member]
Note 16 - Loss Per Common Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)								27,540,899	15,734,500					66,057,792	67,092,382
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.21	$ 0.13	$ 0.36	$ 0.08	$ 0.08	$ 2.33	$ 2.33
Class of Warrant or Right, Exercise Price of Warrants or Rights										$ 0.18	$ 0.18	$ 0.49	$ 0.49			$ 0.48	$ 0.49

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References+ Details

Note 17 - Commitments and Contingencies (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]
Deferred Costs, Leasing, Net, Current	$ 43	$ 39
Operating Leases, Rent Expense, Net	$ 204	$ 200

- Definition

This element represents costs incurred by the lessor that are (a) costs to originate a lease incurred in transactions with independent third parties that (i) result directly from and are essential to acquire that lease and (ii) would not have been incurred had that leasing transaction not occurred and (b) certain costs directly related to specified activities performed by the lessor for that lease. Those activities are: evaluating the prospective lessee's financial condition; evaluating and recording guarantees, collateral, and other security arrangements; negotiating lease terms; preparing and processing lease documents; and closing the transaction. The costs represented by this element are those costs expected to be recognized in (amortized to) earnings within one year from the date of the statement of financial position or operating cycle, if longer.

+ References+ Details

Note 17 - Commitments and Contingencies (Details) - Future Minimum Lease Payments Under Non-cancelable Operating Leases During Subsequent Years (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014
Future Minimum Lease Payments Under Non-cancelable Operating Leases During Subsequent Years [Abstract]
2015	$ 197
2016	206
2017	212
2018	217
2019	242
Thereafter	847
Total	$ 1,921

Note 19 - Related Party Transactions (Details) (USD $)	1 Months Ended	0 Months Ended	1 Months Ended					12 Months Ended		0 Months Ended			12 Months Ended
Note 19 - Related Party Transactions (Details) (USD $)	Feb. 28, 2013 Common Stock [Member] Board of Directors Chairman [Member]	Aug. 05, 2013 Common Stock [Member] Chief Executive Officer [Member]	Feb. 27, 2013 Common Stock [Member]	Feb. 28, 2013 Convertible Series A1 Preferred Stock [Member] Board of Directors Chairman [Member]	Feb. 27, 2013 Convertible Series A1 Preferred Stock [Member] Mr. Chitayat [Member]	Feb. 28, 2013 Convertible Series A2 Preferred Stock [Member] Board of Directors Chairman [Member]	Feb. 27, 2013 Convertible Series A2 Preferred Stock [Member] Mr. Chitayat [Member]	Dec. 31, 2014 Innovative Materials Group [Member]	Dec. 31, 2013 Innovative Materials Group [Member]	Aug. 03, 2013 Chief Executive Officer [Member] Restricted Stock [Member]	Aug. 04, 2014 Chief Executive Officer [Member] Scenario, Forecast [Member]	Aug. 04, 2014 Chief Executive Officer [Member]	Dec. 31, 2014 LLPG [Member]	Dec. 31, 2013 LLPG [Member]
Note 19 - Related Party Transactions (Details) [Line Items]
Royalty Revenue (in Dollars)								$ 8,000	$ 6,000
Conversion of Stock, Shares Converted				58,600	28,928	260,710	109,528
Conversion of Stock, Shares Issued	10,387,883		4,626,840
Sale of Stock, Number of Shares Issued in Transaction		400,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period										1,200,000
Common Stock, Shares, Sold											500,000	500,000
Revenue from Related Parties (in Dollars)													$ 0	$ 0

- Definition

Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.

+ References+ Details

Note 20 - Subsequent Events (Details) (Subsequent Event [Member], USD $) In Thousands, except Share data, unless otherwise specified	Jan. 27, 2015 Equity Incentive Plan 2015 [Member]	Feb. 24, 2015
Note 20 - Subsequent Events (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	40,000,000
Line of Credit Facility, Maximum Borrowing Capacity		$ 2,000

Note 1 - Description of Business (Details)	12 Months Ended
Note 1 - Description of Business (Details)	Dec. 31, 2014
Disclosure Text Block [Abstract]
Percentages of Stronger than Zirconium Titanium Liquidmetal Alloys	250.00%

Note 6 - Prepaid Expenses and Other Current Assets (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Prepaid Expenses And Other Current Assets [Abstract]
Prepaid Expense and Other Assets, Current	$ 374	$ 412

Note 18 - 401(k) Savings Plan (Details)	12 Months Ended
Note 18 - 401(k) Savings Plan (Details)	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	15.00%

Note 2 - Summary of Significant Accounting Policies (Details) - Fair Value of Items Measured on a Recurring Basis (Fair Value, Inputs, Level 2 [Member], Fair Value, Measurements, Recurring [Member], USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Measurements, Recurring [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Fair Value of Items Measured on a Recurring Basis [Line Items]
Warrant Liabilities	$ 2,005	$ 4,921

Note 8 - Patents and Trademarks, Net (Details) - Accumulated Amortization (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Note 8 - Patents and Trademarks, Net (Details) - Accumulated Amortization [Line Items]
Αccumulatеd amortization	$ (1,709)	$ (1,605)
Purchased and Licensed Patent Rights [Member]
Note 8 - Patents and Trademarks, Net (Details) - Accumulated Amortization [Line Items]
Αccumulatеd amortization	(500)	(483)
Internally Developed Patents [Member]
Note 8 - Patents and Trademarks, Net (Details) - Accumulated Amortization [Line Items]
Αccumulatеd amortization	(1,103)	(1,022)
Trademarks [Member]
Note 8 - Patents and Trademarks, Net (Details) - Accumulated Amortization [Line Items]
Αccumulatеd amortization	$ (106)	$ (100)